REVOLADE™ 50mg (Eltrombopag Olamine)

Description

Revolade (Eltrombopag Olamine) 50mg is an oral thrombopoietin receptor agonist used to treat chronic immune thrombocytopenia (ITP), thrombocytopenia associated with chronic hepatitis C, and severe aplastic anemia in patients who are refractory to other treatments. It works by stimulating the thrombopoietin receptor on bone marrow progenitor cells, thereby promoting the proliferation and differentiation of megakaryocytes to increase platelet production. Administered once daily on an empty stomach, it offers a targeted and convenient oral treatment option for patients with dangerously low platelet counts who are at risk of serious bleeding complications. It should be used under strict specialist supervision with regular monitoring of liver function, blood counts, and ophthalmic examinations, as it carries risks of hepatotoxicity, thromboembolic events, and cataracts with prolonged use.